<?xml version='1.0' encoding='utf-8'?>
<document id="28447323"><sentence text="Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics."><entity charOffset="104-117" id="DDI-PubMed.28447323.s1.e0" text="Valproic Acid" /><entity charOffset="122-132" id="DDI-PubMed.28447323.s1.e1" text="Carbapenem" /><pair ddi="false" e1="DDI-PubMed.28447323.s1.e0" e2="DDI-PubMed.28447323.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s1.e0" e2="DDI-PubMed.28447323.s1.e1" /></sentence><sentence text="Human in vitro and dog in vitro/in vivo researches indicate that the drug-drug interaction (DDI) of decreased plasma valproic acid (VPA) concentration by co-administration of carbapenem antibiotics is caused by inhibition of acylpeptide hydrolase (APEH)-mediated VPA acylglucuronide (VPA-G) hydrolysis by carbapenems"><entity charOffset="117-130" id="DDI-PubMed.28447323.s2.e0" text="valproic acid" /><entity charOffset="132-135" id="DDI-PubMed.28447323.s2.e1" text="VPA" /><entity charOffset="175-185" id="DDI-PubMed.28447323.s2.e2" text="carbapenem" /><entity charOffset="284-289" id="DDI-PubMed.28447323.s2.e3" text="VPA-G" /><entity charOffset="305-316" id="DDI-PubMed.28447323.s2.e4" text="carbapenems" /><entity charOffset="263-273" id="DDI-PubMed.28447323.s2.e5" text="VPA" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e0" e2="DDI-PubMed.28447323.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e1" e2="DDI-PubMed.28447323.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e1" e2="DDI-PubMed.28447323.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e1" e2="DDI-PubMed.28447323.s2.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e1" e2="DDI-PubMed.28447323.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e1" e2="DDI-PubMed.28447323.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e2" e2="DDI-PubMed.28447323.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e2" e2="DDI-PubMed.28447323.s2.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e2" e2="DDI-PubMed.28447323.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e2" e2="DDI-PubMed.28447323.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e5" e2="DDI-PubMed.28447323.s2.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e5" e2="DDI-PubMed.28447323.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e5" e2="DDI-PubMed.28447323.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e3" e2="DDI-PubMed.28447323.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s2.e3" e2="DDI-PubMed.28447323.s2.e4" /></sentence><sentence text=" In this study, we investigated VPA disposition and APEH activities in TK-NOG chimeric mice, whose livers were highly replaced with human hepatocytes, to evaluate the utility of this animal model and the clinical relevance of the DDI mechanism"><entity charOffset="32-34" id="DDI-PubMed.28447323.s3.e0" text="VPA" /></sentence><sentence text="" /><sentence text="VPA and VPA-G concentrations in plasma, urinary excretion of VPA-G and APEH activity in humanized livers were measured after co-administration of VPA with meropenem (MEPM) to chimeric mice"><entity charOffset="155-164" id="DDI-PubMed.28447323.s5.e0" text="meropenem" /><entity charOffset="166-170" id="DDI-PubMed.28447323.s5.e1" text="MEPM" /><entity charOffset="0-3" id="DDI-PubMed.28447323.s5.e2" text="VPA" /><entity charOffset="8-11" id="DDI-PubMed.28447323.s5.e3" text="VPA" /><entity charOffset="61-64" id="DDI-PubMed.28447323.s5.e4" text="VPA" /><entity charOffset="146-149" id="DDI-PubMed.28447323.s5.e5" text="VPA" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e2" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e2" e2="DDI-PubMed.28447323.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e3" e2="DDI-PubMed.28447323.s5.e3" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e3" e2="DDI-PubMed.28447323.s5.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e3" e2="DDI-PubMed.28447323.s5.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e3" e2="DDI-PubMed.28447323.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e3" e2="DDI-PubMed.28447323.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e4" e2="DDI-PubMed.28447323.s5.e4" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e4" e2="DDI-PubMed.28447323.s5.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e4" e2="DDI-PubMed.28447323.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e4" e2="DDI-PubMed.28447323.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e5" e2="DDI-PubMed.28447323.s5.e5" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e5" e2="DDI-PubMed.28447323.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e5" e2="DDI-PubMed.28447323.s5.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e0" e2="DDI-PubMed.28447323.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28447323.s5.e0" e2="DDI-PubMed.28447323.s5.e1" /></sentence><sentence text="" /><sentence text="After co-administration with MEPM to the chimeric mice, plasma VPA concentration more rapidly decreased than without the co-administration"><entity charOffset="63-65" id="DDI-PubMed.28447323.s7.e0" text="VPA" /><entity charOffset="29-31" id="DDI-PubMed.28447323.s7.e1" text="MEPM" /><pair ddi="false" e1="DDI-PubMed.28447323.s7.e1" e2="DDI-PubMed.28447323.s7.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s7.e1" e2="DDI-PubMed.28447323.s7.e0" /></sentence><sentence text=" An increase in plasma AUC and urinary excretion of VPA-G was also observed"><entity charOffset="52-55" id="DDI-PubMed.28447323.s8.e0" text="VPA" /></sentence><sentence text=" APEH activity in humanized livers was strongly inhibited even at 24Â h after co-administration of MEPM to the chimeric mice"><entity charOffset="98-100" id="DDI-PubMed.28447323.s9.e0" text="MEPM" /></sentence><sentence text="" /><sentence text="The DDI of VPA with carbapenems was successfully observed in chimeric mice with humanized livers"><entity charOffset="20-31" id="DDI-PubMed.28447323.s11.e0" text="carbapenems" /><entity charOffset="11-21" id="DDI-PubMed.28447323.s11.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.28447323.s11.e1" e2="DDI-PubMed.28447323.s11.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s11.e1" e2="DDI-PubMed.28447323.s11.e0" /></sentence><sentence text=" The DDI was caused by long-lasting inhibition of hepatic APEH-mediated VPA-G hydrolysis by carbapenems, which strongly supports the APEH-mediated mechanism of the clinical DDI"><entity charOffset="92-103" id="DDI-PubMed.28447323.s12.e0" text="carbapenems" /><entity charOffset="72-82" id="DDI-PubMed.28447323.s12.e1" text="VPA" /><pair ddi="false" e1="DDI-PubMed.28447323.s12.e1" e2="DDI-PubMed.28447323.s12.e1" /><pair ddi="false" e1="DDI-PubMed.28447323.s12.e1" e2="DDI-PubMed.28447323.s12.e0" /></sentence><sentence text=" This is the first example showing the usefulness of chimeric mice with humanized livers for evaluation of a DDI via non-cytochrome P450 enzyme" /><sentence text="" /></document>